Conjunctival goblet cells density and preservative-free tafluprost therapy for glaucoma: anin vivoconfocal microscopy and impression cytology study

Benzalkonium chloride induces anterior chamber inflammation in previously untreated patients with ocular hypertension as measured by flare meter: a randomized clinical trial

(2012) Anna M. Stevens et al.   ACTA OPHTHALMOLOGICA

Tafluprost: a novel prostaglandin analog for treatment of glaucoma

(2011) Mina B. Pantcheva et al.   ADVANCES IN THERAPY

Efficacy and safety of tafluprost 0.0015% versus latanoprost 0.005% eye drops in open-angle glaucoma and ocular hypertension: 24-month results of a randomized, double-masked phase III study

(2010) Hannu Uusitalo et al.   ACTA OPHTHALMOLOGICA

Preservatives in eyedrops: The good, the bad and the ugly

(2010) Christophe Baudouin et al.   PROGRESS IN RETINAL AND EYE RESEARCH

In vivo confocal microscopy of conjunctival goblet cells in patients with Sjogren's syndrome dry eye

(2009) J. Hong et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

CREB Mediates Prostaglandin F2 -Induced MUC5AC Overexpression

(2009) W.-C. Chung et al.   JOURNAL OF IMMUNOLOGY

Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride

(2008) H Liang et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

In VitroEffects of Preservative-Free Tafluprost and Preserved Latanoprost, Travoprost, and Bimatoprost in a Conjunctival Epithelial Cell Line

(2008) Emmanuelle Brasnu et al.   CURRENT EYE RESEARCH

German register for glaucoma patients with dry eye. I. Basic outcome with respect to dry eye

(2008) Carl Erb et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY